approached significanceP = 0.078
FTD mutation carriers with higher baseline CSF rejuvenation composite levels demonstrated slower global cognitive and functional declines, and slower plasma NfL increases which approached significance ( P = 0.078), relationships that were not evident in clinically normal non-carrier adults ( Table 2 ; Fig. 2 ; Supplementary Fig. 1 ).